[Immunosuppressive therapy].
D000470:Alkaloids / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D016026:Bone Marrow Transplantation; D003424:Crohn Disease / Q000188:drug therapy; D003524:Cyclosporins / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000188:drug therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008208:Lymphatic System / Q000276:immunology; D009103:Multiple Sclerosis / Q000188:drug therapy; D009157:Myasthenia Gravis / Q000188:drug therapy; D009393:Nephritis / Q000188:drug therapy
D000470:Alkaloids; D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000961:Antilymphocyte Serum; D000963:Antimetabolites; D003524:Cyclosporins; D007166:Immunosuppressive Agents
Immunsuppressive Therapie.